Evidence map›Paper›PMID 25409592›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2015

Hippocampal volume in healthy controls given 3-day stress doses of hydrocortisone.

E Sherwood Brown, Haekyung Jeon-Slaughter, Hanzhang Lu, Rhoda Jamadar, Sruthy Issac, Mujeeb Shad, Daren Denniston, Carol Tamminga, Alyson Nakamura, Binu P Thomas

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. A randomized, double-blind, placebo-controlled trial of lamotrigine for prescription corticosteroid effects on the human hippocampus.European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology · 2019
    Trial
  3. Review
  4. Article
  5. Observational
  6. Article
  7. Two cases of steroid dementia showing partial recovery during 2-year follow-up.PCN reports : psychiatry and clinical neurosciences · 2022
    Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Behavioral and structural adaptations to stress.Frontiers in neuroendocrinology · 2018
    Review
  13. Toward valid and reliable brain imaging results in eating disorders.The International journal of eating disorders · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Hippocampal volume in patients with asthma: Results from the Dallas Heart Study.The Journal of asthma : official journal of the Association for the Care of Asthma · 2017
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

E Sherwood BrownDepartment of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Haekyung Jeon-SlaughterDepartment of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Hanzhang LuThe Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Rhoda JamadarDepartment of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Sruthy IssacDepartment of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Mujeeb ShadDepartment of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Daren DennistonDepartment of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Carol TammingaDepartment of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Alyson NakamuraDepartment of Psychiatry, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Binu P ThomasThe Advanced Imaging Research Center, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
The University of Texas Southwestern Medical Center · USAdvanced Imaging Research (United States) · US

Funding

TRANSGENIC COREP01DA008227 · NIDA · YALE UNIVERSITY · PI NESTLER, ERIC J. · 1993 to 2018
$28.1M
REPRESSIVE HISTONE AND DNA METHYLATION IN RODENT DEPRESSION MODELSP50MH096890 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ALLIS, CHARLES DAVID · 2012 to 2021
$20.2M
Development of a Model to Examine Corticosteroid Effects on the HippocampusR21MH078182 · NIMH · UT SOUTHWESTERN MEDICAL CENTER · PI BROWN, E SHERWOOD · 2008 to 2009
$389k
NIDA NIH HHS P01 DA008227NIMH NIH HHS MH078182NIMH NIH HHS P50 MH096890NIMH NIH HHS R21 MH078182
6 · The paper itself

Abstract

In animal models, corticosterone elevations are associated with hippocampal changes that can be prevented with phenytoin. In humans, Cushing's syndrome and long-term prescription corticosteroid use are associated with a reduction in the hippocampal volume. However, little is known about the effects of short-term corticosteroid administration on the hippocampus. The current report examines changes in the hippocampal volume during a brief hydrocortisone exposure and whether volumetric changes can be blocked by phenytoin. A randomized, double-blind, placebo-controlled, within-subject crossover study was conducted in healthy adults (n=17). Participants received hydrocortisone (160 mg/day)/placebo, phenytoin/placebo, both medications together, or placebo/placebo, with 21-day washouts between the conditions. Structural MRI scans and cortisol levels were obtained following each medication condition. No significant difference in the total brain volume was observed with hydrocortisone. However, hydrocortisone was associated with a significant 1.69% reduction in the total hippocampal volume compared with placebo. Phenytoin blocked the volume reduction associated with hydrocortisone. Reduction in hippocampal volume correlated with the change in cortisol levels (r=-0.58, P=0.03). To our knowledge, this is the first report of structural hippocampal changes with brief corticosteroid exposure. The correlation between the change in hippocampal volume and cortisol level suggests that the volume changes are related to cortisol elevation. Although the findings from this pilot study need replication, they suggest that the reductions in hippocampal volume occur even during brief exposure to corticosteroids, and that hippocampal changes can, as in animal models, be blocked by phenytoin. The results may have implications both for understanding the response of the hippocampus to stress as well as for patients receiving prescription corticosteroids.

Indexed as

AdolescentAdultCentral Nervous System AgentsCross-Over StudiesDouble-Blind MethodFemaleHippocampusHumansHydrocortisoneMagnetic Resonance ImagingMaleMiddle AgedOrgan SizePhenytoinPilot ProjectsTime FactorsCentral Nervous System AgentsHydrocortisonePhenytoin

Identifiers

PMID25409592
PMCPMC4367466
OpenAlexW1979092375

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.